Richland WA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced that two dogs with different cancer types were treated using Vivos Inc.’s Isopet® therapy on November 27 at our pilot clinic, Vista Veterinary Hospital in Kennewick, WA.

One dog with hemangiosarcoma and another dog with hemangiopericytoma were treated. Each patient had multiple tumors that were treated in a single session. Both patients were released on the same day in time for Thanksgiving. In addition to treating two new cancer types, we also demonstrated the ability to treat multiple tumors per pet in one treatment session. The single treatment session per pet remains an important differentiator of the Isopet® therapy as compared to external beam therapy.

Further, we established a process that will allow for the treatment of more than one patient per day at Vista. The “Therapy Wednesday” approach allows us to reduce the cost per therapy and is well suited for Isopet® on demand availability and single procedure per patient treatment protocol...

About Vivos Inc. (OTCQB:RDGL) >> Read Full Release